Atossa Therapeutics, Inc. (ATOS)
Atossa Therapeutics Market Cap : 15.92M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 15.92M |
| November 19, 2026 | 17.46M |
| November 18, 2026 | 18.06M |
| November 17, 2026 | 18.96M |
| November 16, 2026 | 19.26M |
| November 13, 2026 | 19.56M |
| November 12, 2026 | 19.36M |
| November 11, 2026 | 20.26M |
| November 10, 2026 | 21.36M |
| November 09, 2026 | 21.26M |
| November 06, 2026 | 21.16M |
| November 05, 2026 | 20.16M |
| November 04, 2026 | 21.16M |
| November 03, 2026 | 23.25M |
| November 02, 2026 | 22.95M |
| October 30, 2026 | 21.66M |
| October 29, 2026 | 22.25M |
| October 28, 2026 | 23.65M |
| October 27, 2026 | 23.75M |
| October 26, 2026 | 24.45M |
| October 23, 2026 | 25.95M |
| October 22, 2026 | 27.14M |
| October 21, 2026 | 25.25M |
| October 20, 2026 | 25.35M |
| October 19, 2026 | 25.55M |
| Date | Value |
|---|---|
| October 16, 2026 | 29.04M |
| October 15, 2026 | 26.45M |
| October 14, 2026 | 27.74M |
| October 13, 2026 | 25.55M |
| October 12, 2026 | 23.84M |
| October 09, 2026 | 24.35M |
| October 08, 2026 | 24.15M |
| October 07, 2026 | 24.55M |
| October 06, 2026 | 24.45M |
| October 05, 2026 | 24.45M |
| October 02, 2026 | 23.35M |
| October 01, 2026 | 22.65M |
| September 30, 2026 | 19.46M |
| September 29, 2026 | 19.86M |
| September 28, 2026 | 19.56M |
| September 25, 2026 | 18.96M |
| September 24, 2026 | 20.46M |
| September 23, 2026 | 21.75M |
| September 22, 2026 | 22.55M |
| September 21, 2026 | 22.45M |
| September 18, 2026 | 22.15M |
| September 17, 2026 | 23.95M |
| September 16, 2026 | 24.15M |
| September 15, 2026 | 23.65M |
| September 14, 2026 | 24.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| PEG Ratio | -0.0103 |
| Price to Book Value | 0.7322 |
| Price | 1.595 |
| Earnings Yield | -244.5% |
| PEGY Ratio | -0.0103 |